Difference between revisions of "Part:BBa K4447001"
Line 20: | Line 20: | ||
In our project, erythromycin C-12 hydroxylase <b>(EC 1.14.13.154)</b> is used as a detector for the presence of erythromycin by catalyzing the oxidation of two stereoisomers of erythromycin, erythromycin B and D, to erythromycin C, requiring NADPH as a reagent and, therefore, obtaining NADP+ as a reaction product. Consequently, it is possible to evaluate the presence of erythromycin through a coupled reaction employing a NADP+/NADPH colorimetric assay. The following image shows the complete reaction according to Stassi and collaborators (1993): | In our project, erythromycin C-12 hydroxylase <b>(EC 1.14.13.154)</b> is used as a detector for the presence of erythromycin by catalyzing the oxidation of two stereoisomers of erythromycin, erythromycin B and D, to erythromycin C, requiring NADPH as a reagent and, therefore, obtaining NADP+ as a reaction product. Consequently, it is possible to evaluate the presence of erythromycin through a coupled reaction employing a NADP+/NADPH colorimetric assay. The following image shows the complete reaction according to Stassi and collaborators (1993): | ||
− | [[Image:EryK_reaction_TecMonterreyGDL.jpeg|600px|center|thumb|<b>Figure 1. Chemical reaction for erythromycin C-12 hydroxylase (EryK).]] | + | [[Image:EryK_reaction_TecMonterreyGDL.jpeg|600px|center|thumb|<b>Figure 1</b>. Chemical reaction for erythromycin C-12 hydroxylase (EryK).]] |
Erythromycin C-12 hydroxylase (EryK) is a monomer with 397 amino acids in length and 43.8 kDa in weight. According to Savino <i>et al.</i> (2009), it binds one heme b(iron(II)-protoporphyrin IX) group per subunit as a cofactor. Lambalot <i>et al.</i> (1995) reported a Michaelis constant of 8 μM for erythromycin D, concluding that it shows a 1200-1900-fold preference for erythromycin D over the alternative substrate erythromycin B. This enzyme participates in various molecular and biological processes, ranging from macrolide biosynthetic processes to oxidoreductase reactions. Next, we present the three-dimensional structure of EryK generated by AlphaFold2 using MMSeqs2 (Mirdita et al., 2022). This structure is as follows: | Erythromycin C-12 hydroxylase (EryK) is a monomer with 397 amino acids in length and 43.8 kDa in weight. According to Savino <i>et al.</i> (2009), it binds one heme b(iron(II)-protoporphyrin IX) group per subunit as a cofactor. Lambalot <i>et al.</i> (1995) reported a Michaelis constant of 8 μM for erythromycin D, concluding that it shows a 1200-1900-fold preference for erythromycin D over the alternative substrate erythromycin B. This enzyme participates in various molecular and biological processes, ranging from macrolide biosynthetic processes to oxidoreductase reactions. Next, we present the three-dimensional structure of EryK generated by AlphaFold2 using MMSeqs2 (Mirdita et al., 2022). This structure is as follows: |
Revision as of 23:06, 28 September 2022
EryK coding sequence
Erythromycin C-12 hydroxylase coding sequence from Saccharopolyspora erythraea. The enzyme is responsible for the stereospecific hydroxylation of the macrolactone ring present in erythromycin D and erythromycin B.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal XhoI site found at 1197
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Contents
Usage and Biology
In the last few years, much attention has been drawn to emerging contaminants due to their severe effects on human health and the lack of information about them. Among them, erythromycin has risen as a potential threat in developing antimicrobial resistance, and being capable of detecting it in water bodies can lead to the generation of measurements capable of degrading it.
In our project, erythromycin C-12 hydroxylase (EC 1.14.13.154) is used as a detector for the presence of erythromycin by catalyzing the oxidation of two stereoisomers of erythromycin, erythromycin B and D, to erythromycin C, requiring NADPH as a reagent and, therefore, obtaining NADP+ as a reaction product. Consequently, it is possible to evaluate the presence of erythromycin through a coupled reaction employing a NADP+/NADPH colorimetric assay. The following image shows the complete reaction according to Stassi and collaborators (1993):
Erythromycin C-12 hydroxylase (EryK) is a monomer with 397 amino acids in length and 43.8 kDa in weight. According to Savino et al. (2009), it binds one heme b(iron(II)-protoporphyrin IX) group per subunit as a cofactor. Lambalot et al. (1995) reported a Michaelis constant of 8 μM for erythromycin D, concluding that it shows a 1200-1900-fold preference for erythromycin D over the alternative substrate erythromycin B. This enzyme participates in various molecular and biological processes, ranging from macrolide biosynthetic processes to oxidoreductase reactions. Next, we present the three-dimensional structure of EryK generated by AlphaFold2 using MMSeqs2 (Mirdita et al., 2022). This structure is as follows:
References
[1]. Lambalot, R. H., Cane, D. E., Aparicio, J. J., & Katz, L. (1995). Overproduction and characterization of the erythromycin C-12 hydroxylase, EryK. Biochemistry, 34(6), 1858–1866. https://doi.org/10.1021/bi00006a006
[2]. Mirdita, M., Schütze, K., Moriwaki, Y. et al.(2022). ColabFold: making protein folding accessible to all. Nat Methods 19, 679–682. https://doi.org/10.1038/s41592-022-01488-1
[3]. Savino, C., Montemiglio, L. C., Sciara, G., Miele, A. E., Kendrew, S. G., Jemth, P., Gianni, S., & Vallone, B. (2009). Investigating the structural plasticity of a cytochrome P450: three-dimensional structures of P450 EryK and binding to its physiological substrate. The Journal of biological chemistry, 284(42), 29170–29179. https://doi.org/10.1074/jbc.M109.003590
[4]. Stassi, D., Donadio, S., Staver, M. J., & Katz, L. (1993). Identification of a Saccharopolyspora erythraea gene required for the final hydroxylation step in erythromycin biosynthesis. Journal of bacteriology, 175(1), 182–189. https://doi.org/10.1128/jb.175.1.182-189.1993